NOV 09, 2017 12:00 PM PST

On the road to realizing tissue engineering's transformative potential: multidisciplinary approach to accelerate bench-to-clinic transition

Speakers
  • CEO and Co-Founder, EpiBone
    Biography
      Nina Tandon is CEO and co-founder of EpiBone, the world's first company growing living human bones for skeletal reconstruction. She is the co-author of Super Cells: Building with Biology, a book that explores the new frontier of biotech. She is a TED Senior Fellow, Adjunct Professor of Electrical Engineering at the Cooper Union and a former Staff Associate Postdoctoral Researcher in the Laboratory for Stem Cells and Tissue Engineering, Columbia University. She has a Bachelor's in Electrical Engineering from the Cooper Union, a Master's in Bioelectrical Engineering from MIT, a PhD in Biomedical Engineering, and an MBA from Columbia University. Her PhD research focused on studying electrical signaling in the context of tissue engineering, and has worked with cardiac, skin, bone, and neural tissue.
    • Director of Therapeutics, Organovo
      Biography
        Dr. Shepherd has more than 17 years of experience in Tissue Engineering and Regenerative Medicine research. Dr. Shepherd's research in vascular biology and microvascular tissue engineering has been focused on the ability to use creative approaches to generate microvascular networks to support the fabrication and surgical implantation of prevascularized neotissues. In addition to these research interests, he has successfully led early-stage research programs in liver biology, oncology and directed differentiation of stem cells within 3D and bioprinted tissues. Prior to joining Organovo, he was an Associate Research Scientist at the Yale School of Medicine, where he also conducted postdoctoral training. In addition to his appointment at Yale, he was a staff perfusionist at the University of Connecticut Health Center. Dr. Shepherd is a board certified clinical perfusionist (C.C.P.), received his Ph.D. in Physiological Sciences from the University of Arizona and a B.S. in Zoology from the University of Washington.

      Abstract:

      A panel of experts will discuss recent advances and current challenges for the successful development and application of human tissue for drug screening, tissue replacement and eventually organ replacement.


      Show Resources
      You May Also Like
      MAY 22, 2018 08:00 AM PDT
      C.E. CREDITS
      MAY 22, 2018 08:00 AM PDT
      DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
      MAY 03, 2018 11:00 AM PDT
      MAY 03, 2018 11:00 AM PDT
      DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
      APR 27, 2018 10:00 AM PDT
      C.E. CREDITS
      APR 27, 2018 10:00 AM PDT
      DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
      AUG 15, 2018 08:00 AM PDT
      C.E. CREDITS
      AUG 15, 2018 08:00 AM PDT
      DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
      JUN 29, 2018 09:00 AM PDT
      C.E. CREDITS
      JUN 29, 2018 09:00 AM PDT
      DATE: June 29, 2018TIME: 09:00AM PDT, 12:00PM EDT There is significant epidemiological evidence to suggest that the consumption of a high-broccoli diet is associated with a r...
      MAY 29, 2018 09:00 AM PDT
      C.E. CREDITS
      MAY 29, 2018 09:00 AM PDT
      Recent advances in immuno-oncology research has proven the critical role of immune cells in cancer therapy. Deep understanding of the interaction and phenotype of immune and tumor cells withi...
      Loading Comments...